December 1, 2015
Recommended Topic Related To:


"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...


Side Effects


Healon (sodium hyaluronate) is extremely well tolerated after injection into human eyes. A transient rise of intraocular pressure postoperatively has been reported in some cases.

In posterior segment surgery intraocular pressure rises have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of Healon (sodium hyaluronate) .

Rarely, postoperative inflammatory reactions liritis, hypopyon as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to Healon (sodium hyaluronate) has not been established.

Read the Healon (sodium hyaluronate) Side Effects Center for a complete guide to possible side effects


No information provided.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/8/2004

Side Effects

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.